Table 2.

Frequencies of functional dyspepsia over time across treatment.

	Score	Supplementation group (n = 65)	Placebo group (n = 61)
T1 (after 14 days)	0	10 (15.4%)	26 (42.6%)
	1	26 (40%)	27 (44.3%)
	2	25 (38.5%)	8 (13.1%)
	3	4 (6.1%)	0 (0)
T2 (after 28 days)	0	9 (13.8%)	29 (47.5%)
	1	15 (23.1%)	17 (27.9%)
	2	21 (32.3%)	13 (21.3%)
	3	20 (30.8%)	2 (3.3%)
	2 + 3	41 (63.1%)	15 (24.6%)
	1 + 2 + 3	56 (86.2%)	32 (52.4%)